1. PREFACE
1.1. Overview
1.2. Scope of the Report
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
3. INTRODUCTION
3.1. Chapter Overview
3.2. Background of Organ-on-Chip
3.3. Classification of Organ-on-Chip
3.3.1. Single Organ Chip
3.3.2. Disease / Therapeutic Indication Specific Chip
3.3.3. Multi Organ Chip
3.4. Advantages and Limitations of Organ-on-Chip
3.5. Applications of Organ-on-Chip
3.6. Future Perspectives
4. ORGAN-ON-CHIP: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Organ-on-Chip: List of Products
4.2.1. Analysis by Type of Offering(s)
4.2.2. Analysis by Status of Development
4.2.3. Analysis by Type of Technology / Platform
4.2.4. Analysis by Number of Chips in a Plate
4.2.5. Analysis by Material Used for Construction of Chip / Plate
4.2.6. Analysis by Type of Polymer
4.2.7. Analysis by Compatible Tissue / Organ
4.2.8. Analysis by Application Area(s)
4.3. Organ-on-Chip: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Leading Developers: Analysis by Number of Organ-on-Chip Products
5. ORGAN-ON-CHIP DEVELOPERS: COMPANY PROFILES
5.1. Chapter Overview
5.2. BEOnChip
5.2.1. Company Overview
5.2.2. Product Portfolio
5.2.3. Recent Developments and Future Outlook
5.3. Dynamic42
5.3.1. Company Overview
5.3.2. Product Portfolio
5.3.3. Recent Developments and Future Outlook
5.4. Emulate
5.4.1. Company Overview
5.4.2. Product Portfolio
5.4.3. Recent Developments and Future Outlook
5.5. Mimetas
5.5.1. Company Overview
5.5.2. Product Portfolio
5.5.3. Recent Developments and Future Outlook
5.6. SynVivo
5.6.1. Company Overview
5.6.2. Product Portfolio
5.6.3. Recent Developments and Future Outlook
5.7 TissUse
5.7.1. Company Overview
5.7.2. Product Portfolio
5.7.3. Recent Developments and Future Outlook
5.8 uFluidix
5.8.1. Company Overview
5.8.2. Product Portfolio
5.8.3. Recent Developments and Future Outlook
6. PATENT ANALYSIS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Organ-on-Chip: Patent Analysis
6.3.1. Analysis by Type of Patent
6.3.2. Analysis by Publication Year
6.3.3. Analysis by Annual Granted Patents
6.3.4. Analysis by Annual Patent Application
6.3.5. Analysis by Annual Granted Patents and Patent Application
6.3.6. Analysis by Location of Headquarters
6.3.7. Analysis by Type of Applicant
6.3.8. Analysis by Patent Age
6.3.9. Analysis by Geographical Region
6.3.10. Analysis by CPC Symbols
6.3.11. Leading Industry Players: Analysis by Number of Patents
6.3.12. Leading Non-Industry Players: Analysis by Number of Patents
6.3.13 Leading Inventors: Analysis by Number of Patents
6.4. Patent Benchmarking Analysis
6.4.1. Analysis by Patent Characteristics
6.5. Analysis by Patent Valuation
7. BRAND POSITIONING MATRIX
7.1. Chapter Overview
7.2 Methodology
7.3. Key Parameters
7.4. Companies Providing Organ-on-Chip
7.4.1. Brand Positioning Matrix: BiomimX
7.4.2. Brand Positioning Matrix: Emulate
7.4.3. Brand Positioning Matrix: NETRI
7.4.4. Brand Positioning Matrix: SynVivo
7.4.5. Brand Positioning Matrix: TissUSe
7.4.6. Brand Positioning Matrix: uFluidix
8. ACADEMIC GRANTS ANALYSIS
8.1 Chapter Overview
8.2. Scope and Methodology
8.3. Organ-on-Chip: Academic Grants Analysis
8.3.1. Analysis by Year of Grant Award
8.3.2. Analysis by Grant Amount Awarded
8.3.3. Analysis by Administering Institute Center
8.3.4. Analysis by Support Period
8.3.5. Analysis by Administering Institute Center and Support Period
8.3.6. Analysis by Administering Institute Center and Amount Awarded (USD Million)
8.3.7. Analysis by Type of Grant Application
8.3.8. Analysis by Purpose of Grant
8.3.9. Analysis by Activity Code
8.3.10. Word Cloud Analysis: Emerging Focus Area
8.3.11. Analysis by Study Section Involved
8.3.12. Popular NIH Departments: Analysis by Number of Grants
8.3.13. Analysis by Type of Recipient Organization
8.3.14. Analysis by Support Period and Amount Awarded
8.3.15. Popular Recipient Organizations: Analysis by Number of Grants
8.3.16. Popular Recipient Organizations: Analysis by Amount Awarded
8.3.17. Popular Recipient Organizations: Analysis by Geographical Location
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Organ-on-Chip: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Most Active Players: Analysis by Number of Partnerships
9.3.4. Analysis by Geographical Region
9.3.4.1 Intercontinental and Intracontinental Agreements
10. FUNDING AND INVESTMENT ANALYSIS
10.1. Chapter Overview
10.2. Organ-on-Chip: List of Funding and Investments
10.2.1. Analysis by Annual Instances
10.2.2. Analysis by Amount Invested per Year
10.2.3. Analysis by Type of Funding
10.2.4. Analysis by Type of Funding and Year of Establishment
10.2.5. Analysis by Type of Funding and Amount Invested
10.2.6. Analysis of Amount Invested by Geographical Region
10.2.7. Analysis by Purpose of Funding
10.2.8. Analysis by Associated Organ / System
10.2.9. Analysis by Therapeutic Area
10.2.10. Most Prominent Investors: Analysis by Number of Instances
10.2.11. Most Active Players: Analysis by Number of Funding Instances
10.2.12. Most Active Players: Analysis by Amount Raised
10.2.13. Summary of Investments
11. CASE STUDY: SCAFFOLD-FREE 3D CELL CULTURE SYSTEMS
11.1. Chapter Overview
11.2. Scaffold-free Products: Market Landscape
11.2.1. Analysis by Status of Development
11.2.2. Analysis by Type of Product
11.2.3. Analysis by Source of 3D Cultured Cells
11.2.4. Analysis by Method Used for Fabrication
11.2.5. Analysis by Material Used for Fabrication
11.2.6. Analysis by Type of Product and Source of 3D Cultured Cells
11.2.7. Analysis by Type of Product and Method Used for Fabrication
11.3. Scaffold Free Products: Developer Landscape
11.3.1. Analysis by Year of Establishment
11.3.2. Analysis by Company Size
11.3.3. Analysis by Location of Headquarters
11.4. Leading Developers: Analysis by Number of Scaffold Free Products
11.5. Tree Map Representation: Analysis by Type of Product and Company Size
12. ORGAN-ON-CHIP: MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Organ-on-Chip Market, 2022-2035
12.3.1. Global Organ-on-Chip Market, 2022-2035: Distribution by Type of Product
12.3.1.1. Organ-on-Chip Market for Organ(s) based Models, 2022-2035
12.3.1.2. Organ-on-Chip Market for Disease(s) based Models, 2022-2035
12.3.2. Global Organ-on-Chip Market, 2022-2035: Distribution by Application Area
12.3.2.1. Organ-on-Chip Market for Cancer Research, 2022-2035
12.3.2.2. Organ-on-Chip Market for Drug Discovery and Toxicity Testing, 2022-2035
12.3.2.3. Organ-on-Chip Market for Stem Cell Research, 2022-2035
12.3.2.4. Organ-on-Chip Market for Tissue Engineering and Regenerative Medicine, 2022-2035
12.3.3. Global Organ-on-Chip Market, 2022-2035: Distribution by Purpose
12.3.3.1. Organ-on-Chip Market for Research Purposes, 2022-2035
12.3.3.2. Organ-on-Chip Market for Therapy Development, 2022-2035
12.3.4. Global Organ-on-Chip Market, 2022-2035: Distribution by Key Geographical Regions
12.3.4.1. Organ-on-Chip Market in North America, 2022-2035
12.3.4.2. Organ-on-Chip Market in Europe, 2022-2035
12.3.4.3. Organ-on-Chip Market in Asia-Pacific, 2022-2035
12.3.4.4. Organ-on-Chip Market in Rest of the World, 2022-2035
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Cherry Biotech
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Pierre Gaudriault, Chief Business Development Officer
14.3. EDmicBio
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Matt Dong-Heon Ha, Chief Executive Officer
14.4. Hesperos
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Michael Shuler, President
14.5. Lena Biosciences
14.5.1. Company Snapshot
14.5.2. Interview Transcript: Jelena Vukasinovic, Chief Executive Officer
14.6. react4life
14.6.1. Company Snapshot
14.6.2. Interview Transcript: Maurizio Aiello, Chief Executive Officer
14.7. Screenin3D
14.7.1. Company Snapshot
14.7.2. Interview Transcript: Michele Zagnoni, Chief Executive Officer
List Of Figures
Figure 2.1. Executive Summary: Overall Market Landscape of Organ-on-Chip Products / Technologies
Figure 2.2. Executive Summary: Patent Analysis
Figure 2.3. Executive Summary: Brand Positioning
Figure 2.4. Executive Summary: Grant Analysis
Figure 2.5. Executive Summary: Partnerships and Collaborations
Figure 2.6. Executive Summary: Funding and Investment Analysis
Figure 2.7. Executive Summary: Organ-on-Chip Market Sizing and Opportunity Analysis
Figure 3.1. Background of Organ-on-Chip
Figure 3.2. Types of Organ-on-Chip
Figure 3.3. Types of Single Organ-on-Chip
Figure 3.4. Advantages and Limitations of Organ-on-chip
Figure 3.5. Applications of Organ-on-Chip in Drug Discovery and Development
Figure 4.1. Organ-on-Chip: Distribution by Type of Offering(s)
Figure 4.2. Organ-on-Chip: Distribution by Type of Model
Figure 4.3. Organ-on-Chip: Distribution by Status of Development
Figure 4.4. Organ-on-Chip: Distribution by Type of Technology / Platform
Figure 4.5. Organ-on-Chip: Distribution by Number of Chips in a Plate
Figure 4.6. Organ-on-Chip: Distribution by Material Used for Construction of Chip / Plate
Figure 4.7. Organ-on-Chip: Distribution by Type of Polymer
Figure 4.8. Organ-on-Chip: Distribution by Compatible Tissue / Organ
Figure 4.9. Organ-on-Chip: Distribution by Application Area(s)
Figure 4.10. Organ-on-Chip: Distribution of Developers by Year of Establishment
Figure 4.11. Organ-on-Chip: Distribution of Developers by Company Size
Figure 4.12. Organ-on-Chip: Distribution of Developers by Location of Headquarters
Figure 4.13. Leading Developers: Distribution by Number of Organ-on-Chip Products
Figure 6.1. Patent Analysis: Distribution by Type of Patents
Figure 6.2. Patent Analysis: Cumulative Distribution by Publication Year
Figure 6.3. Patent Analysis: Distribution by Annual Granted Patents
Figure 6.4. Patent Analysis: Distribution by Annual Patent Applications
Figure 6.5. Patent Analysis: Distribution by Annual Granted Patents and Patent Applications
Figure 6.6. Patent Analysis: Distribution by Location of Headquarters
Figure 6.7. Patent Analysis: Distribution by Type of Applicant
Figure 6.8. Patent Analysis: Distribution by Patent Age
Figure 6.9. Patent Analysis: Distribution by Geographical Region
Figure 6.10. Patent Analysis: Distribution by CPC Symbols
Figure 6.11. Patent Analysis: Distribution by Leading Industry Players
Figure 6.12. Patent Analysis: Distribution by Leading Non-Industry Players
Figure 6.13. Patent Analysis: Distribution by Leading Inventors
Figure 6.14. Patent Analysis: Patent Valuation Analysis
Figure 7.1. Brand Positioning Matrix: BiomimX
Figure 7.2. Brand Positioning Matrix: Emulate
Figure 7.3. Brand Positioning Matrix: NETRI
Figure 7.4. Brand Positioning Matrix: SynVivo
Figure 7.5. Brand Positioning Matrix: TissUse
Figure 7.6. Brand Positioning Matrix: uFluidix
Figure 8.1. Academic Grants Analysis: Distribution by Cumulative Year-wise Trend
Figure 8.2. Academic Grants Analysis: Distribution by Grant Amount Awarded
Figure 8.3. Academic Grants Analysis: Distribution by Funding Institute Center
Figure 8.4. Academic Grants Analysis: Distribution by Support Period
Figure 8.5. Academic Grants Analysis: Distribution by Funding Institute Center and Support Period
Figure 8.6. Academic Grants Analysis: Distribution by Type of Grant
Figure 8.7. Academic Grants Analysis: Distribution by Purpose of Grant
Figure 8.8. Academic Grants Analysis: Distribution by Activity Codes
Figure 8.9. Academic Grants Analysis: Emerging Focus Areas
Figure 8.10. Academic Grants Analysis: Distribution by Study Section
Figure 8.11. Academic Grants Analysis: Distribution by Most Popular NIH Department
Figure 8.12. Academic Grants Analysis: Distribution by Organization
Figure 8.13. Academic Grants Analysis: Distribution by Support Period and Amount Awarded
Figure 8.14. Academic Grants Analysis: Distribution of Popular Recipient Organizations by Number of Grants
Figure 8.15. Academic Grants Analysis: Distribution of Popular Recipient Organizations by Amount Awarded
Figure 8.16. Academic Grants Analysis: Distribution of Popular Recipient Organizations by Geographical Location
Figure 9.1. Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Figure 9.2. Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3. Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Figure 9.4. Partnerships and Collaborations: Distribution by Type of Collaborator
Figure 9.5. Partnerships and Collaborations: Distribution by Target Indication
Figure 9.6. Partnerships and Collaborations: Distribution by Therapeutic Area
Figure 9.7. Partnerships and Collaborations: Distribution by Associated Organ / Tissue
Figure 9.8. Most Active Players: Distribution by Number of Partnerships
Figure 9.9. Partnerships and Collaborations: Distribution by Type of Agreement (Country wise)
Figure 9.10. Partnerships and Collaborations: Distribution by Type of Agreement (Region wise)
Figure 9.11. Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1. Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested (USD Million), 2017-2022
Figure 10.2. Funding and Investment Analysis: Distribution by Type of Funding and Year of Establishment, 2017-2022
Figure 10.3. Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2017-2022
Figure 10.4. Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested (USD Million), 2017-2022
Figure 10.5. Funding and Investment Analysis: Distribution by Type of Funding
Figure 10.6. Funding and Investment Analysis: Distribution by Year and Type of Funding
Figure 10.7. Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 10.8. Funding and Investment Analysis: Distribution by Associated Organ / System
Figure 10.9. Funding and Investment Analysis: Distribution by Target Indication
Figure 10.10. Funding and Investment Analysis: Distribution by Therapeutic Area
Figure 10.11. Funding and Investment Analysis: Distribution by Region
Figure 10.12. Most Active Players: Distribution by Number of Instances
Figure 10.13. Most Active Players: Distribution by Amount Raised (USD Million)
Figure 10.14. Key Investors: Distribution by Number of Funding Instances
Figure 10.15. Funding and Investment Summary, 2017-2022 (USD Million)
Figure 11.1. Scaffold-free 3D Cell Culture Systems: Distribution by Status of Development
Figure 11.2. Scaffold-free 3D Cell Culture Systems: Distribution by Type of Product
Figure 11.3. Scaffold-free 3D Cell Culture Systems: Distribution by Source of 3D Cultured Cells
Figure 11.4. Scaffold-free 3D Cell Culture Systems: Distribution by Method Used for Fabrication
Figure 11.5. Scaffold-free 3D Cell Culture Systems: Distribution by Material Used for Fabrication
Figure 11.6. Scaffold-free 3D Cell Culture Systems: Distribution by Type of Product and Source of 3D Cultured Cells
Figure 11.7. Scaffold-free 3D Cell Culture Systems: Distribution by Type of Product and Method Used for Fabrication
Figure 11.8. Scaffold-free 3D Cell Culture Systems: Distribution of Developers by Year of Establishment
Figure 11.9. Scaffold-free 3D Cell Culture Systems: Distribution of Developers by Company Size
Figure 11.10. Scaffold-free 3D Cell Culture Systems: Distribution of Developers by Location of Headquarters
Figure 11.11. Leading Developers: Analysis by Number of Scaffold Free Products
Figure 11.12. Tree Map Representation: Analysis by Type of Product and Company Size
Figure 12.1. Global Organ-on-Chip Market, 2022-2035 (USD Million)
Figure 12.2. Organ-on-Chip Market: Distribution by Type of Product, 2022 and 2035 (USD Million)
Figure 12.3. Organ-on-Chip Market for Multi-Organ(s) Based Models, 2022-2035 (USD Million)
Figure 12.4. Organ-on-Chip Market for Disease(s) Based Models, 2022-2035 (USD Million)
Figure 12.5. Organ-on-Chip Market: Distribution by Application Area, 2022 and 2035 (USD Million)
Figure 12.6. Organ-on-Chip Market for Cancer Research, 2022-2035 (USD Million)
Figure 12.7. Organ-on-Chip Market for Drug Discovery and Toxicity Testing, 2022-2035 (USD Million)
Figure 12.8. Organ-on-Chip Market for Stem Cell Research, 2022-2035 (USD Million)
Figure 12.9. Organ-on-Chip Market for Tissue Engineering and Regenerative Medicine, 2022-2035 (USD Million)
Figure 12.10. Organ-on-Chip Market: Distribution by Purpose, 2022 and 2035 (USD Million)
Figure 12.11. Organ-on-Chip Market for Research Purposes, 2022-2035 (USD Million)
Figure 12.12. Organ-on-Chip Market for Therapy Development, 2022-2035 (USD Million)
Figure 12.13. Organ-on-Chip Market: Distribution by Key Geographical Regions, 2022 and 2035 (USD Million)
Figure 12.14. Organ-on-Chip Market for North America, 2022-2035 (USD Million)
Figure 12.15. Organ-on-Chip Market for Europe, 2022-2035 (USD Million)
Figure 12.16. Organ-on-Chip Market for Asia-Pacific, 2022-2035 (USD Million)
Figure 12.17. Organ-on-Chip Market for Rest of the World, 2022-2035 (USD Million)
Figure 13.1. Concluding Remarks: Organ-on-Chip Market Landscape
Figure 13.2. Concluding Remarks: Patent Analysis
Figure 13.3. Concluding Remarks: Academic Grant Analysis
Figure 13.4. Concluding Remarks: Partnerships and Collaborations
Figure 13.5. Concluding Remarks: Funding and Investment Analysis
Figure 13.6. Concluding Remarks: Organ-on-Chip Market Sizing and Opportunity Analysis
List Of Tables
Table 4.1. List of Organ-on-Chip Products and Technologies
Table 4.2. List of Organ-on-Chip Developers: Information on Year of Establishment, Company Size, Location of Headquarters, Geographical Region
Table 5.1. Organ-on-Chip Developers: List of Companies Profiled
Table 5.2. BEOnChip: Company Snapshot
Table 5.3. BEonChip: Key Characteristics of Organ-on-Chip Products
Table 5.4. SynVivo: Company Snapshot
Table 5.5. SynVivo: Key Characteristics of Organ-on-Chip Products
Table 5.6. Dynamic42: Company Snapshot
Table 5.7. Dynamic42: Key Characteristics of Organ-on-Chip Products
Table 5.8. Emulate: Company Snapshot
Table 5.9. Emulate: Key Characteristics of Organ-on-Chip Products
Table 5.10. Emulate: Recent Developments and Future Outlook
Table 5.11. Mimetas: Company Snapshot
Table 5.12. Mimetas: Key Characteristics of Organ-on-Chip Products
Table 5.13. Mimetas: Recent Developments and Future Outlook
Table 5.14. TissUse: Company Snapshot
Table 5.15. TissUse: Key Characteristics of Organ-on-Chip Products
Table 5.16. TissUse: Recent Developments and Future Outlook
Table 5.17. uFluidix: Company Snapshot
Table 5.18. uFluidix: Key Characteristics of Organ-on-Chip products
Table 5.19. uFluidix: Recent Developments and Future Outlook
Table 6.1. Patent Analysis: Most Popular CPC Symbols
Table 6.2. Patent Analysis: List of Top CPC Symbols
Table 6.3. Patent Analysis: Categorization based on Weighted Valuation Scores
Table 6.4. Patent Analysis: List of Leading Patents (by Highest Relative Valuation)
Table 7.1. Brand Positioning: List of Brands Positioned
Table 9.1. Organ-on-Chip: List of Partnerships and Collaborations
Table 10.1. Organ-on-Chip: List of Funding and Investments
Table 11.1. Scaffold Free Products: List of Products
Table 11.2. Scaffold Free Developers: List of Developers
Table 14.1. Cherry Biotech: Company / Organization Snapshot
Table 14.2. EDmicBio: Company / Organization Snapshot
Table 14.3. Hesperos: Company / Organization Snapshot
Table 14.4. Lena Biosciences: Company / Organization Snapshot
Table 14.5. react4life: Company / Organization Snapshot
Table 14.6. Screenin3D: Company / Organization Snaps
Table 15.1. Organ-on-Chip: Distribution by Type of Offering
Table 15.2. Organ-on-Chip: Distribution by Type of Model
Table 15.3. Organ-on-Chip: Distribution by Status of Development
Table 15.4. Organ-on-Chip: Distribution by Type of Technology / Platform
Table 15.5. Organ-on-Chip: Distribution by Number of Chips in a Plate
Table 15.6. Organ-on-Chip: Distribution by Material Used for Construction
Table 15.7. Organ-on-Chip: Distribution by Type of Polymer
Table 15.8. Organ-on-Chip: Distribution by Compatible Tissue / Organ
Table 15.9. Organ-on-Chip: Distribution by Application Area(s)
Table 15.10. Organ-on-Chip: Distribution of Developers by Year of Establishment
Table 15.11. Organ-on-Chip: Distribution of Developers by Company Size
Table 15.12. Organ-on-Chip: Distribution of Developers by Location of Headquarters
Table 15.13. Leading Developers: Distribution by Number of Organ-on-Chip Products
Table 15.14. Patent Analysis: Distribution by Type of Patents
Table 15.15. Patent Analysis: Cumulative Distribution by Publication Year
Table 15.16. Patent Analysis: Distribution by Annual Granted Patents
Table 15.17. Patent Analysis: Distribution by Annual Patent Application
Table 15.18. Patent Analysis: Distribution by Annual Granted Patents and Patent Application
Table 15.19. Patent Analysis: Distribution by Location of Headquarters
Table 15.20. Patent Analysis: Distribution by Type of Applicant
Table 15.21. Patent Analysis: Distribution by Patent Age
Table 15.22. Patent Analysis: Distribution by Geographical Region
Table 15.23. Patent Analysis: Distribution by CPC Symbols
Table 15.24. Patent Analysis: Distribution by Leading Industry Players
Table 15.25. Patent Analysis: Distribution by Leading Non-Industry Players
Table 15.26. Patent Analysis: Distribution by Leading Inventors
Table 15.27. Patent Analysis: Patent Valuation Analysis
Table 15.28. Academic Grants Analysis: Distribution by Cumulative Year-wise Trend
Table 15.29. Academic Grants Analysis: Distribution by Grant Amount Awarded
Table 15.30. Academic Grants Analysis: Distribution by Funding Institute Center
Table 15.31. Academic Grants Analysis: Distribution by Support Period
Table 15.32. Academic Grants Analysis: Distribution by Funding Institute Center and Support Period
Table 15.33. Academic Grants Analysis: Distribution by Type of Grant
Table 15.34. Academic Grants Analysis: Distribution by Purpose of Grant
Table 15.35. Academic Grants Analysis: Distribution by Activity Codes
Table 15.36. Academic Grants Analysis: Distribution by Study Section
Table 15.37. Academic Grants Analysis: Distribution by Most Popular Department
Table 15.38. Academic Grants Analysis: Distribution by Organization
Table 15.39. Academic Grants Analysis: Distribution by Support Period and Amount Awarded
Table 15.40. Academic Grants Analysis: Distribution of Popular Recipient Organizations by Number of Grants
Table 15.41. Academic Grants Analysis: Distribution of Popular Recipient Organizations by Amount Awarded
Table 15.42. Academic Grants Analysis: Distribution of Popular Recipient Organizations by Geographical Location
Table 15.43. Partnerships and Collaborations: Distribution by Cumulative Year-wise Trend, 2017-2022
Table 15.44. Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.45. Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Table 15.46. Partnerships and Collaborations: Distribution by Type of Collaborator
Table 15.47. Partnerships and Collaborations: Distribution by Target Indication
Table 15.48. Partnerships and Collaborations: Distribution by Therapeutic Area
Table15.49. Partnerships and Collaborations: Distribution by Associated Organ / Tissue
Table 15.50. Most Active Players: Distribution by Number of Partnerships
Table 15.51. Partnerships and Collaborations: Distribution by Type of Agreement (Country wise)
Table 15.52. Partnerships and Collaborations: Distribution by Type of Agreement (Region wise)
Table 15.53. Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.54. Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested (USD Million), 2017-2022
Table 15.55. Funding and Investment Analysis: Distribution by Year of Establishment and Type of Funding, 2017-2022
Table 15.56. Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2017-2022
Table 15.57. Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested (USD Million), 2017-2022
Table 15.58. Funding and Investment Analysis: Distribution by Type of Funding
Table 15.59. Funding and Investment Analysis: Distribution by Year and Type of Funding
Table 15.60. Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 15.61. Funding and Investment Analysis: Distribution by Associated Organ / Tissue
Table 15.62. Funding and Investment Analysis: Distribution by Target Indication
Table 15.63. Funding and Investment Analysis: Distribution by Therapeutic Area
Table 15.64. Funding and Investment Analysis: Distribution by Region
Table 15.65. Most Active Players: Distribution by Number of Instances
Table 15.66. Most Active Players: Distribution by Amount Raised (USD Million)
Table 15.67. Key Investors: Distribution by Number of Funding Instances
Table 15.68. Scaffold-free 3D Cell Culture Systems: Distribution by Status of Development
Table 15.69. Scaffold-free 3D Cell Culture Systems: Distribution by Type of Product
Table 15.70. Scaffold-free 3D Cell Culture Systems: Distribution by Source of 3D Cultured Cells
Table 15.71. Scaffold-free 3D Cell Culture Systems: Distribution by Method Used for Fabrication
Table 15.72. Scaffold-free 3D Cell Culture Systems: Distribution by Material Used for Fabrication
Table 15.73. Scaffold-free 3D Cell Culture Systems: Distribution by Type of Product and Source of 3D Cultured Cells
Table 15.74. Scaffold-free 3D Cell Culture Systems: Distribution by Type of Product and Method Used for Fabrication
Table 15.75. Scaffold-free 3D Cell Culture Systems: Distribution of Developers by Year of Establishment
Table 15.76. Scaffold-free 3D Cell Culture Systems: Distribution of Developers by Company Size
Table 15.77. Scaffold-free 3D Cell Culture Systems: Distribution of Developers by Location of Headquarters
Table 15.78. Leading Developers: Analysis by Number of Scaffold Free Products
Table 15.79. Tree Map Representation: Analysis by Type of Product and Company Size
Table 15.80. Global Organ-on-Chip Market, Conservative, Base and Optimistic Forecast Scenario, 2022 - 2035 (USD Million)
Table 15.81. Organ-on-Chip Market: Distribution by Type of Product, 2022 and 2035 (USD Million)
Table 15.82. Organ-on-Chip Market for Organ(s) Based Models, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.83. Organ-on-Chip Market for Disease(s) Based Models, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.84. Organ-on-Chip Market: Distribution by Application Area, 2022 and 2035 (USD Million)
Table 15.85. Organ-on-Chip Market for Cancer Research, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.86. Organ-on-Chip Market for Drug Discovery and Toxicity Testing, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.87. Organ-on-Chip Market for Stem Cell Research, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.88. Organ-on-Chip Market for Tissue Engineering and Regenerative Medicine, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.89. Organ-on-Chip Market: Distribution by Purpose, 2022 and 2035 (USD Million)
Table 15.90. Organ-on-Chip Market for Research Purposes, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.91. Organ-on-Chip Market for Therapy Development, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.92. Organ-on-Chip Market: Distribution by Key Geographical Regions, 2022 and 2035 (USD Million)
Table 15.93. Organ-on-Chip Market in North America, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.94. Organ-on-Chip Market in Europe, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.95. Organ-on-Chip Market in Asia-Pacific, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
Table 15.96. Organ-on-Chip Market in Rest of the World, Conservative, Base and Optimistic Forecast Scenario, 2022-2035 (USD Million)
